disease 1,543 words KG: ent-dise-c40379ae 2026-03-25
anxietyapathycorticobasal-syndromedepressionneuropsychiatry
Contents

Neuropsychiatric Features of Corticobasal Syndrome

Disease Info
Depressive symptomsPersistent low mood, anhedonia, sleep disturbance, appetite changes
Vegetative symptomsFatigue, psychomotor retardation, weight loss
Cognitive symptomsWorthlessness, guilt, difficulty concentrating
Suicidal ideationPresent in up to 15-20% of patients
Prefrontal cortexDorsolateral and ventromedial regions
Anterior cingulate cortexEmotional processing and regulation
Basal gangliaLimbic loop involvement
Serotonergic pathwaysDorsal raphe nuclei projections
SSRIsFirst-line for chronic anxiety
PsychotherapyCognitive-behavioral therapy adapted for cognitive impairment
ExerciseRegular physical activity has antidepressant effects
Caregiver supportEducation and respite to prevent caregiver depression
DatabasesOMIMOrphanetClinicalTrialsPubMed

Knowledge Graph

Related Hypotheses (25)

Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
PARP1 Inhibition Therapy
Score: 0.58
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55

Related Analyses (19)

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived